Abivax Bowel-Disease Drug Hits Goals in Trial, But Shares Plunge on Safety Worries

1 day ago 1

Shares fell sharply aft the biotech said immoderate patients developed crab successful a late-stage objective proceedings for the bowel-disease cause that was unrelated to the treatment.

Read Entire Article

Abivax Bowel-Disease Drug Hits Goals in Trial, But Shares Plunge on Safety Worries

Related

Could lifting weights actually help you live longer?

Rubio Suggests U.S. Return to Global Vaccine Program in Rebu...

Health Care Roundup: Market Talk

Extreme weather can whip up anxiety. A safety plan can help

Trump Megadonor Gave $5.5 Million Estate to Robert F. Kenned...

Only the Right Tests Can Stop This Ebola Outbreak. Congo Has...

Popular

Two of America’s Thorniest Political Issues Are Dividing an ...

President Trump said Wednesday that Iran was miscalculating ...

'When I was 14 I thought I was dying'

Bari Weiss Names Nick Bilton to Lead CBS’s ’60 Minutes’ in M...

USPS, DHL partner in a $10 billion 'last-mile' delivery agre...